Mass Spectrometry as a Workhorse for Preclinical Drug Discovery: Special Emphasis on Drug Metabolism and Pharmacokinetics

Veeravalli, Vijayabhaskar & Mohan Vamsi Madgula, Lakshmi & Srivastava, Pratima

10.5772/intechopen.88385. In book: Mass Spectrometry – Future Perceptions and Applications

Investigation of the inhibition of eight major human cytochrome P450 isozymes by a probe substrate cocktail in vitro with emphasis on CYP2E1

Valicherla GR, Mishra A, Lenkalapelly S, Jillela B, Francis FM, Rajagopalan L, Srivastava P

Xenobiotica 1-21. 10.1080/00498254.2019.1581301

Oral Pharmacokinetics of Sildenafil in the presence of CYP3A4-inducer and -inhibitor using cannulated and non-cannulated male Swiss Albino mice

Kumar S, Jadi R, Lakkimsetti B, Ravulapalli SY, Tiwari SK, Srivastava P, Paliwal R, Rajagopalan LE

IJAR 9: 30-34

Physiologically based pharmacokinetic (PBPK) modeling and simulation in drug discovery and development

Abdul Naveed Shaik & Ansar Ali Khan

ADMET & DMPK 7(1) (2019) 1-3; DOI: 10.5599/admet.667